European Journal of Epidemiology

, Volume 29, Issue 2, pp 119–132

Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk

  • Mathilde His
  • Laurent Zelek
  • Mélanie Deschasaux
  • Camille Pouchieu
  • Emmanuelle Kesse-Guyot
  • Serge Hercberg
  • Pilar Galan
  • Paule Latino-Martel
  • Jacques Blacher
  • Mathilde Touvier
CANCER

DOI: 10.1007/s10654-014-9884-5

Cite this article as:
His, M., Zelek, L., Deschasaux, M. et al. Eur J Epidemiol (2014) 29: 119. doi:10.1007/s10654-014-9884-5

Abstract

Experimental studies provided evidence about mechanisms by which cholesterol, especially high density lipoprotein cholesterol (HDL-C), could influence carcinogenesis, notably through antioxidant and anti-inflammatory properties. However, prospective studies that investigated the associations between specific lipid metabolism biomarkers and cancer risk provided inconsistent results. The objective was to investigate the prospective associations between total cholesterol (T-C), HDL-C, low density lipoprotein cholesterol, apolipoproteins A1 (apoA1) and B, and triglycerides and overall, breast and prostate cancer risk. Analyses were performed on 7,557 subjects of the Supplémentation en Vitamines et Minéraux Antioxydants Study, a nationwide French cohort study. Biomarkers of lipid metabolism were measured at baseline and analyzed regarding the risk of first primary incident cancer (N = 514 cases diagnosed during follow-up, 1994–2007), using Cox proportional hazards models. T-C was inversely associated with overall (HR1mmol/L increment = 0.91, 95 % CI 0.82–1.00; P = 0.04) and breast (HR1mmol/L increment = 0.83, 95 % CI 0.69–0.99; P = 0.04) cancer risk. HDL-C was also inversely associated with overall (HR1mmol/L increment = 0.61, 95 % CI 0.46–0.82; P = 0.0008) and breast (HR1mmol/L increment = 0.48, 95 % CI 0.28–0.83; P = 0.009) cancer risk. Consistently, apoA1 was inversely associated with overall (HR1g/L increment = 0.56, 95 % CI 0.39–0.82; P = 0.003) and breast (HR1g/L increment = 0.36, 95 % CI 0.18–0.73; P = 0.004) cancer risk. This prospective study suggests that pre-diagnostic serum levels of T-C, HDL-C and ApoA1 are associated with decreased overall and breast cancer risk. The confirmation of a role of cholesterol components in cancer development, by further large prospective and experimental studies, may have important implications in terms of public health, since cholesterol is already crucial in cardiovascular prevention.

Keywords

Prospective studyNeoplasmsBreast neoplasmsCholesterolHigh-density lipoproteinApolipoprotein A1

Abbreviations

ApoA1

Apolipoprotein A1

ApoB

Apolipoprotein B

BMI

Body mass index

CI

Confidence interval

HDL-C

High density lipoprotein cholesterol

HR

Hazard ratio

LDL-C

Low density lipoprotein cholesterol

Q

Quartile

SU.VI.MAX

Supplémentation en Vitamines et Minéraux Antioxydants

T-C

Total cholesterol

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Mathilde His
    • 1
  • Laurent Zelek
    • 1
    • 2
  • Mélanie Deschasaux
    • 1
  • Camille Pouchieu
    • 1
  • Emmanuelle Kesse-Guyot
    • 1
  • Serge Hercberg
    • 1
    • 3
  • Pilar Galan
    • 1
  • Paule Latino-Martel
    • 1
  • Jacques Blacher
    • 1
    • 4
  • Mathilde Touvier
    • 1
  1. 1.EREN, SMBH Paris 13Sorbonne Paris Cité Research Center, Nutritional Epidemiology Research Team, Inserm (U1153), Inra, Cnam, Paris 13 UniversityBobigny CedexFrance
  2. 2.Oncology DepartmentAvicenne HospitalBobigny CedexFrance
  3. 3.Public Health DepartmentAvicenne HospitalBobigny CedexFrance
  4. 4.Diagnosis and Therapeutic CenterHôtel-Dieu HospitalParisFrance